Clidet no. 403 (Pty) Ltd and Midas Ltd (47/LM/Jul02) [2002] ZACT 47 (24 July 2002)

55 Reportability
Competition Law

Brief Summary

Competition Law — Merger Approval — Management buy-out of Midas Limited by Clidet No. 403 (Pty) Ltd — The Competition Tribunal approved the merger without conditions, determining that it would not substantially prevent or lessen competition. The merger involved the transfer of Midas's business to Clidet 403, a special purpose vehicle created for this purpose, with no overlap in product markets between the merging parties. The Tribunal found no public interest concerns, including retrenchments, arising from the merger.

COMPETITION TRIBUNAL 
REPUBLIC OF SOUTH AFRICA
        Case No: 47/LM/Jul02
In the large merger between: 
Clidet No. 403 (Pty) Ltd 
and
Midas Limited
_______________________________________________________________________
Tribunal’s Reasons for Decision
_______________________________________________________________________
Approval
The   Competition   Tribunal   issued   a   Merger   Clearance   Certificate   on   23   July   2002  
approving the merger without conditions. The reasons for our decision are set out below.
The merger
The transaction
The transaction involves a management buy­out wherein the business of Midas Limited  
(“Midas”) will be transferred to Clidet No. 403 (Pty) Ltd (“Clidet 403”). 
The primary acquiring firm is Clidet 403, which is a special purpose vehicle created to  
hold   the   investment   of   ABSA   Bank   Ltd   in   Midas.   The   firm   is   not   involved   in   any  
economic activity. The shareholding in Clidet 403 is as follows:
Midas Investment Trust (“MIT”) 1 40%
Clidet No 373 2 20%
ABSA 40% 
1 MIT has been formed specifically for the purpose of holding the interest of management in Midas. The  
firm is not involved in any other business activities.
2 The shelf company, Clidet No 373 (Pty) Ltd is currently controlled by MIT, which means that MIT  
indirectly holds the 20% through Clidet No. 373. The reason for this is to facilitate the transfer of this 20%  
shareholding in Clidet 403 to a suitable black economic empowerment partner at some stage in the future.

The primary target firm is Midas, which is controlled by Dorbyl Limited. Midas is a  
public   company   quoted   under   the   “Industrial   –   Retail”   list   of   the   JSE   Securities  
Exchange.
According to the parties Dorbyl is currently restructuring its businesses and disposing its  
non­core assets, which includes  inter alia  Midas.
Evaluating the merger
Midas operates through a national hub and spoke distribution channel and reaches the  
retail market through 320 own franchisees which can be segmented into franchises that  
offer a wide range of products and services to motorists, trading as Midas Parts Centres,  
franchises that offer auto­electrical specialist services, trading as Motolek, franchises that  
service the diesel fuel injection and turbo markets, trading as Adco and franchise that  
offers   clutch   and   brake   services   trading   as   CBS.   Midas   also   sells   products   to   other  
independent spare part shops, workshops, fleets, chain stores, engineering shops, etc.
In substance the merger amounts to existing Midas management buying out of Dorbyl’s  
interests   with   the   assistance   of   ABSA   as   their   funding   partner.   Since   neither  
management,   (who   will   constitute   the   majority   shareholder   through   their   direct   and  
indirect holdings) or ABSA control any competitor of Midas there is thus no increase in  
concentration because the product markets of the merging parties do not overlap. 
In light of the above we agree with the Commission’s recommendation that the merger  
will not substantially prevent or lessen competition.
Public interest
The merger will not result in retrenchments and does not raise any other public interest  
issues.
24 July 2002
N. Manoim Date
Concurring: D. Lewis, M. Moerane
For the merging parties:   Cliffe Dekker Attorneys
2

For the Competition Commission:  L Sikhitha
3